Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Related structures:
AlphaFold database: A0A3Q8IJ73
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 6 |
GO:0016407 | acetyltransferase activity | 5 | 6 |
GO:0016740 | transferase activity | 2 | 6 |
GO:0016746 | acyltransferase activity | 3 | 6 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 6 |
GO:0008080 | N-acetyltransferase activity | 6 | 1 |
GO:0016410 | N-acyltransferase activity | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 9 | 11 | PF00675 | 0.577 |
CLV_PCSK_KEX2_1 | 9 | 11 | PF00082 | 0.577 |
CLV_PCSK_SKI1_1 | 107 | 111 | PF00082 | 0.480 |
DOC_CYCLIN_RxL_1 | 101 | 111 | PF00134 | 0.484 |
DOC_CYCLIN_RxL_1 | 84 | 93 | PF00134 | 0.484 |
DOC_MAPK_gen_1 | 68 | 76 | PF00069 | 0.496 |
DOC_PP1_RVXF_1 | 105 | 111 | PF00149 | 0.584 |
LIG_14-3-3_CanoR_1 | 80 | 85 | PF00244 | 0.484 |
LIG_deltaCOP1_diTrp_1 | 131 | 139 | PF00928 | 0.463 |
LIG_deltaCOP1_diTrp_1 | 148 | 158 | PF00928 | 0.659 |
LIG_FHA_1 | 62 | 68 | PF00498 | 0.496 |
LIG_LIR_Apic_2 | 131 | 135 | PF02991 | 0.496 |
LIG_LIR_Nem_3 | 138 | 143 | PF02991 | 0.496 |
LIG_PDZ_Class_2 | 153 | 158 | PF00595 | 0.599 |
LIG_SH2_CRK | 20 | 24 | PF00017 | 0.537 |
LIG_SH2_NCK_1 | 29 | 33 | PF00017 | 0.552 |
LIG_SH2_STAP1 | 143 | 147 | PF00017 | 0.572 |
LIG_SH2_STAP1 | 20 | 24 | PF00017 | 0.537 |
LIG_SH2_STAT5 | 90 | 93 | PF00017 | 0.450 |
LIG_TRAF2_1 | 117 | 120 | PF00917 | 0.484 |
MOD_CK2_1 | 36 | 42 | PF00069 | 0.502 |
MOD_GlcNHglycan | 54 | 57 | PF01048 | 0.484 |
MOD_NEK2_2 | 4 | 9 | PF00069 | 0.712 |
MOD_PIKK_1 | 13 | 19 | PF00454 | 0.563 |
MOD_PKA_2 | 79 | 85 | PF00069 | 0.456 |
MOD_SUMO_for_1 | 117 | 120 | PF00179 | 0.484 |
MOD_SUMO_rev_2 | 60 | 69 | PF00179 | 0.496 |
TRG_ENDOCYTIC_2 | 20 | 23 | PF00928 | 0.535 |
TRG_ER_diArg_1 | 8 | 10 | PF00400 | 0.587 |
TRG_ER_diArg_1 | 84 | 87 | PF00400 | 0.459 |
TRG_NES_CRM1_1 | 17 | 30 | PF08389 | 0.538 |
TRG_Pf-PMV_PEXEL_1 | 107 | 111 | PF00026 | 0.256 |
TRG_Pf-PMV_PEXEL_1 | 112 | 116 | PF00026 | 0.486 |
TRG_Pf-PMV_PEXEL_1 | 87 | 92 | PF00026 | 0.484 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PE86 | Leptomonas seymouri | 81% | 100% |
A4HPE1 | Leishmania braziliensis | 89% | 100% |
A4ICI2 | Leishmania infantum | 99% | 100% |
O17731 | Caenorhabditis elegans | 29% | 99% |
P21673 | Homo sapiens | 35% | 92% |
P48026 | Mus musculus | 35% | 92% |
P49431 | Mus saxicola | 35% | 92% |
P79081 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 32% | 94% |
Q01612 | Mesocricetus auratus | 34% | 92% |
Q28999 | Sus scrofa | 35% | 92% |
Q3T0Q0 | Bos taurus | 35% | 92% |
Q53HX3 | Leishmania major | 95% | 100% |
Q6P8J2 | Mus musculus | 34% | 93% |
Q7PCJ8 | Bos taurus | 38% | 93% |
Q7PCJ9 | Sus scrofa | 37% | 93% |
Q8AXL1 | Gallus gallus | 37% | 92% |
Q96F10 | Homo sapiens | 36% | 93% |
Q9JHW6 | Cricetulus griseus | 34% | 92% |
Q9ZV05 | Arabidopsis thaliana | 24% | 69% |
Q9ZV06 | Arabidopsis thaliana | 25% | 67% |